The Biosynthetic Gene Cluster for the 26-Membered Ring Polyene Macrolide Pimaricin
A NEW POLYKETIDE SYNTHASE ORGANIZATION ENCODED BY TWO SUBCLUSTERS SEPARATED BY FUNCTIONALIZATION GENES*

Jesús F. AparicioDagger , Angel J. Colina, Elvira Ceballos§, and Juan F. Martín

From the Institute of Biotechnology INBIOTEC, Science Park of León, Avda. del Real, n° 1, 24006 León, Spain

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The biosynthetic gene cluster for the 26-membered ring of the polyene macrolide pimaricin extends for about 110 kilobase pairs of contiguous DNA in the genome of Streptomyces natalensis. Two sets of polyketide synthase (PKS) genes are separated by a group of small polyketide-functionalizing genes. Two of the polyketide synthase genes, pimS0 and pimS1, have been fully sequenced and disrupted proving the involvement of each of these genes in pimaricin biosynthesis. The pimS0 gene encodes a relatively small acetate-activating PKS (~193 kDa) that appears to work as a loading protein which "presents" the starter unit to the second PKS subunit. The pimS1 gene encodes a giant multienzyme (~710 kDa) harboring 15 activities responsible for the first four cycles of chain elongation in pimaricin biosynthesis, resulting in formation of the polyene chromophore.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Polyketides are a large and highly diverse group of natural products (1) that includes antibacterial, antifungal, anticancer, antiparasitic, and immunosuppressant activities, among others. Despite their structural diversity, these metabolites are synthesized by a common pathway in which units derived from acetate, propionate, or butyrate are condensed onto the growing chain by a polyketide synthase (PKS)1 in a process resembling fatty acid biosynthesis (2-4), except that the beta -keto function introduced at each elongation step may undergo all, part, or none of a reductive cycle comprising beta -ketoreduction, dehydration, and enoyl reduction (5). The structural variety in this class of products arises from choice of monomers, the extent of beta -ketoreduction, and dehydration and the stereochemistry of each chiral center. Yet further diversity is produced by functionalization of the polyketide chain by the action of glycosylases, methyltransferases, and oxidative enzymes.

Macrocyclic polyketides are produced mainly by Streptomyces and related filamentous bacteria through the action of so-called type I modular PKSs (5-8). These enzymes usually consist of several extremely large polypeptides in which different modules (sets) of enzymic activities catalyze each successive round of elongation (6, 7). Characterization of such PKS systems is not only an important scientific challenge but a necessary start to the study of factors that control the specificity and extent of chain extension, which are largely unknown (4, 9, 10).

Polyene macrolides are a group of macrocyclic polyketides that interact with membrane sterols and are, therefore, active against fungi but not bacteria (11, 12). Pimaricin (Fig. 1) represents a prototype molecule of glycosylated polyenes (13) important for antifungal therapy and promising for antiviral activity, stimulation of the immune response, and action in synergy with other antifungal drugs or antitumor compounds (14). It is produced by Streptomyces natalensis and widely utilized in the food industry to prevent mold contamination of cheese and other nonsterile foods (i.e. cured meats). The macrolide rings of polyene antibiotics are larger (up to twice in size) than those of standard 14- or 16-membered nonpolyene macrolides (11). Their rings include a chromophore of conjugated double bonds (the characteristic polyene structure). The genetic determination of the length of the polyene and the chromophore and the ring size of these giant macrolide rings is intriguing.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of the aglycone core of pimaricin. Mycosamine (M) is attached to the hydroxyl at C-15 in the pimaricin molecule. The 12 C-C bonds formed by the polyketide synthase are boxed and numbered in italics. Bold lines indicate the building units. Lactonization of the acyl chain between C-1 and C-25 results in the formation of the pimaricinolide ring.

Despite the general interest of polyene macrolides, very little is known about their biosynthetic routes and the gene clusters encoding them. We have, therefore, undertaken the cloning of a large Streptomyces gene cluster involved in the biosynthesis of the polyketide backbone that forms the 26-membered tetraene macrolide ring of pimaricin. pimS1, the gene responsible for the first four rounds of chain elongation has been sequenced, and its modular nature has been established. pimS0, a gene required for chain initiation has been also studied. Gene disruption studies provide evidence for the involvement of pimS0 and pimS1 in pimaricin biosynthesis.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains, Cloning Vectors, and Phages-- S. natalensis ATCC 27448 was used as the source of DNA in the construction of the genomic library. Escherichia coli strain XL1-Blue MR was used for obtaining SuperCos 1 cosmid (Stratagene) recombinant derivatives and also served as a host for plasmid subcloning in plasmids pBluescript (Stratagene) pUC18 and pUC19. Candida utilis (synonym Pichia jadinii) CECT 1061 was used for bioassay experiments. Phage KC515 (c+ attP::tsr::vph), a ØC31-derived phage (15), was used for gene disruption experiments (16). Streptomyces lividans JII 1326 (17) served as a host for phage propagation and transfection. Standard conditions for culture of Streptomyces species and isolation of phages were as described by Hopwood et al. (16).

S. natalensis was routinely grown in YEME medium (16). Sporulation was achieved in TBO medium (2% (w/v) tomato paste, 2% (w/v) oats flakes, 2.5% (w/v) agar) at 30 °C. For pimaricin production, the strain was grown in phosphate-limited SPG medium (2.5% (w/v) soya peptone, 0.5 mM ZnSO4·7H2O, 2% (w/v) glucose, pH 7.5) as described by Martín and Demain (18).

Genetic Procedures-- Standard genetic techniques with E. coli and in vitro DNA manipulations were as described by Sambrook et al. (19). E. coli was transformed by the procedure of Hanahan (20). Recombinant DNA techniques in Streptomyces species and isolation of Streptomyces total and phage DNA were performed as described previously (16).

The library of size-fractionated genomic DNA was screened using probes derived from the rapamycin PKS genes from Streptomyces hygroscopicus (5, 8) and from the candicidin genes of Streptomyces griseus (21). A positive clone (Cos 9) containing PKS genes was used as the starting point for chromosome walking. Cosmid clones were obtained that extended over a contiguous 110-kb region of the S. natalensis chromosome, and individual inserts were subcloned into plasmid vectors. Sequencing templates were obtained by random subcloning of fragments generated by controlled partial HaeIII digestions.

DNA Sequencing-- DNA sequencing was accomplished by the dideoxynucleotide chain termination method (22) on double-stranded DNA templates with an Applied Biosystems model 310 sequencer (Foster City, CA.). Subclone junctions were verified by direct sequencing of cosmid clones, using as primer, sets of synthesized internal oligonucleotides. Each nucleotide was sequenced a minimum of three times on both strands.

Computer analysis of DNA and protein sequences. Primary DNA sequence data were analyzed and assembled by using software from DNAStar (Madison, Wis.). DNA and protein sequences were analyzed with the University of Wisconsin Genetics Computer Group programs (23).

Assay of Pimaricin Production-- To assay pimaricin in culture broths, 0.5 ml of culture was extracted with 2 ml of butanol, and the organic phase was diluted in water-saturated butanol to bring the absorbance at 319 nm in the range of 0.1 to 0.4 absorbance units. Control solutions of pure pimaricin (Gist-Brocades, Delft, The Netherlands) were used as control. To confirm the identity of pimaricin, a UV-visible absorption spectrum (absorption peaks at 319, 304, 291, and 281 nm) was routinely determined in a Hitachi U-2001 spectrophotometer. For routine tests, the fungicidal activity of pimaricin was tested by bioassay using C. utilis CECT 1061 as test organism.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification and Cloning of the Pimaricin Synthase Genes-- The pimaricin biosynthetic genes were identified by hybridization using as probes DNA from both the PKS genes of S. hygroscopicus that direct the biosynthesis of the macrocyclic polyketide immunosuppressant rapamycin (5, 8) and the PKS genes of S. griseus that are involved in the biosynthesis of the heptaene macrolide candicidin (21). A cosmid library was constructed, and a total of 110 kb of contiguous DNA was cloned. Fig. 2 shows the cosmid coverage of this region.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Organization of the pimaricin biosynthetic gene cluster. A, shading indicates NotI, BamHI, EcoRI, or SphI fragments hybridizing with probe a (coding for most of module 1 KS domain). Fragments b and c were used for gene disruption (see Fig. 3). Only NotI (N) restriction sites are indicated on the map. The cosmid clones studied are shown. B, nucleotide sequence information obtained from the ends of the NotI fragments is indicated on the map. The direction of transcription is indicated by the arrowheads. pimS1, pimD, and pimS0 have been completely sequenced and analyzed (see text). KR, beta -ketoreductase; DH, dehydratase; Cho Ox, cholesterol oxidase. C, organization of AT domains involved in pimaricin biosynthesis. Ac, AT domain that incorporates an acetate extender unit into the growing polyketide chain; Pr, AT domain specific for propionate. Specificities were assigned by comparison with divergent sequence motifs correlated with the substrate specificity of (methyl)malonyl-CoA:acyl carrier protein transacylase domains in modular polyketide synthases (27). Open circles indicate deduced AT domains whose specificity could not be established. Numbers over the circles indicate the order in which each AT is used during the biosynthesis of the pimaricin polyketide backbone. 0 refers to the AT presumably involved in the loading of the starter unit (see text).

All the cosmids were mapped with restriction enzymes NotI, SphI, BamHI, and EcoRI. Internal NotI fragments were the same size as their homologous fragments of S. natalensis total DNA, suggesting that the cloned DNA was not rearranged.

Overall Organization of the Region Involved in Pimaricin Biosynthesis-- NotI, SphI, BamHI, and EcoRI restriction fragments of the isolated cosmids were probed with a labeled 0.7-kb NotI fragment from Cos9 (fragment a in Fig. 2A). This probe was chosen because it codes for a KS domain of a type I PKS (the most invariant domain in modular PKSs; Ref. 8), as judged by sequence comparison alignments with other modular PKSs (see below). Because of the modular nature of PKS genes, the use of a highly conserved probe at moderate stringency hybridization gave us a gross indication of the extent of the PKS-coding DNA. Thus, about 13 kb of the rightmost sequences of Cos 37 (Fig. 2) did not hybridize with the probe, suggesting that the end of the PKS part of the gene cluster is located within cosmid 37. This hybridization approach also indicated that approximately 9 kb of the leftmost sequences of Cos13 (Fig. 2) were beyond the PKS portion of the cluster. In addition, no hybridization signal was observed in the central area of the cluster (Fig. 2), suggesting that a possible non-PKS region (~10 kb) is located between sets of PKS genes in this central area.

To confirm these results, all the NotI fragments within the 110 kb of cloned chromosomal DNA were subcloned into pBluescript, and their ends were sequenced. Fig. 2B shows the function to which translated peptides from the sequence showed similarity and the direction of transcription. The first set of PKS genes pimSO and pimS1 (Fig. 2) were fully sequenced. The second set of PKS genes are transcribed in opposite orientation to the first set and appears to encode two additional modular PKSs. Several non-PKS-accompanying proteins were found to be encoded between the two large sets of PKS domains, further corroborating the above results. One of these activities showed significant sequence similarity with permeases within the ATP-dependent ABC transporter superfamily, whereas another one showed high similarity to cholesterol oxidases of other Streptomyces species. Other activities with counterparts in the protein data base included a sensory transduction protein, a ferredoxin, and a cytochrome P-450 monooxygenase. All these genes can be plausibly assigned roles in pimaricin biosynthesis. On the right side of the cluster, a cytochrome P-450 monooxygenase-like gene (pimD) was also identified and fully sequenced.2 No other open reading frames with known homologies were detected on the left side of the 110-kb region studied.

Functional Inactivation of the PKS Blocks Pimaricin Production-- The involvement of the cloned DNA region in pimaricin biosynthesis was tested by gene disruption. Because S. natalensis ATCC 27448 has so far proven to be highly resistant to transformation with commonly used Streptomyces plasmids, a different approach for delivering of DNA into this strain was used. We took advantage of the ability of phage KC515, an attP-defective ØC31 derivative (15), to infect S. natalensis to introduce DNA into this strain.

A 3.3-kb NotI subclone in pBluescript containing an internal coding region to PKS domains on the right side of the cluster (fragment b in Fig. 2A) was used as a source of DNA for subcloning into KC515 (Fig. 3). A 3.25-kb SacI fragment (containing most of the insert and the SacI site of the polylinker of pBluescript) was cloned into KC515, and the recombinant phage DNA was transfected into S. lividans protoplasts, as described elsewhere (16). Further infection of S. natalensis with the recombinant phage allowed the selection for lysogen formation. Because the KC515 phage lacks attP, it can form lysogens only by homologous recombination into the chromosome (Fig. 3A).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Disruption of pimS1 blocks pimaricin production. A, predicted restriction enzyme polymorphism caused by gene disruption. The SacI restriction pattern before and after disruption is shown. The probe is shown as dashed bars. The fragment used for gene disruption derives from fragment b in Fig. 2 (see text for details). N, NotI; Sa, SacI. Note that there is one NotI restriction site in the phage DNA that is not shown. B, Southern hybridization of the SacI-digested chromosomal DNA of the wild type (lane 1) and the mutant (lane 2). C, bioassay for pimaricin production in the S. natalensis wild type strain (wt) and in the derived disruption mutant using C. utilis as the test organism.

Several lysogens of S. natalensis were obtained by selection for thiostrepton resistance, and their pimaricin production was tested by bioassay against C. utilis. No antibiotic activity was observed in the tested lysogens (Fig. 3C) as compared with the halos of antifungal activity produced by the wild type strain. One of these disrupted mutants was selected, and its culture broth was extracted with butanol. It showed no traces of pimaricin by the spectrophotometric assay (see "Experimental Procedures"). Southern hybridization (Fig. 3B) showed that integration of the phage DNA caused a restriction pattern change. When the 3.25-kb SacI fragment used to construct the KC515 derivative was used as a probe (shown as dashed bars in Fig. 3A) for genomic DNA hybridization, it hybridized with the 9.3-kb SacI fragment of the wild type. However, in the disrupted mutant, a new 3.25 SacI fragment also hybridized with the probe (Fig. 3B), indicating that a single crossover event had occurred. The observed hybridizing bands corresponded exactly to those expected according to the integration shown in Fig. 3.

The PKS Region on the Right End of the Cluster Contains Modules for the First Steps of Pimaricin Biosynthesis-- An approximately 35-kb area spanning the DNA fragment used for disruption (b in Fig. 2A) was sequenced and analyzed. One of the most striking features of the sequenced region is the presence of an extraordinarily large open reading frame named pimS1 (Fig. 2) encoding a protein of 6797 amino acids, including the initiating methionine. The molecular mass of the protein encoded by pimS1 (hereafter named PIMS1) was calculated to be 710,250 Da as a monomer. Comparison of protein PIMS1 with sequences of the SWISSPROT protein sequence data base revealed a significant similarity to known fatty acid and polyketide synthases. When the sequence of the pimS1 gene product was compared with itself, clear evidence was obtained for internal reiterations, indicating that PIMS1 consists of 4 modules for chain extension (Fig. 4B).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Organization of polyketide synthases PIMS0 and PIMS1. A, repeated modules within PIMS1. Dot matrix comparison of module 1 with the whole of PIMS S1. Comparison was carried out with a window of 50 and a stringency of 33. Gaps in modules 2, 3, and 4 correspond to the presence of dehydratase domains within such modules. B and C, domain organization within PIMS1 and PIMS0, respectively. Each domain is represented by a rectangle (filled as shown in the bottom of the figure) whose length is proportional to the size of the domain. For domain designations, see the abbreviations footnote or the following: CoL, carboxylic acid:CoA ligase; KR, beta -ketoreductase; DH, dehydratase.

Module 1 contains KS, AT, beta -ketoreductase, and ACP domains. Modules 2, 3, and 4, however, contain extra dehydratase domains that account for a stretch of three contiguous enoyl groups in the final pimaricin molecule (see below). In all dehydratase domains of PIMS, there is a good alignment with the dehydratase domain from 6-deoxyerythronolide B synthase module 4 and the dehydratase domains from the RAPS proteins of the rapamycin synthase (8); the active-site motif HXXXGXXXXP (24, 25) is present. In addition, KS domains are highly conserved (70-80% identity over the whole domain) and contain the two invariant His residues located 135 and 173 amino acids C-terminal of the active-site Cys, as previously stated for other PKS ketosynthase domains (Ref. 8 and references therein). The beta -ketoreductase domains of PIMS contain a potential motif for NADP(H) binding (GXGXXGXXXA) at the N-terminal end of the domain (26), as occurs with all the previously published beta -ketoreductase domains except for those of the rapamycin synthase (8). ACP domains in PIMS are also highly conserved. Remarkably, ACP from PIMS module 1 has the active-site sequence QGFDS, whereas all previously identified prokaryotic ACPs have Leu adjacent to the Gly.

AT domains of type I modular PKSs fall into two distinct groups, depending upon whether the substrate for the AT is 2S-methylmalonyl-CoA (9) or malonyl-CoA, as discussed in detail elsewhere (27). When PIMS1 AT domains were compared with the divergent motifs found in AT domains of type I PKSs, a convincing match was seen with the malonyl-CoA ("acetate") consensus (Pim 01, 02, 03, and 04 in Fig. 5), thus suggesting that these AT domains incorporate acetate extender units into the growing polyketide chain.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 5.   Alignment of the sequences for the divergent motifs and the active sites found in AT domains of type I polyketide synthases. Pim 1 to 10 indicate identified AT domains present in modules 1 to 10 of the PKS for pimaricin biosynthesis. Ery01, Ole 5, Sor 5 and Rap02, Rap10, and Rap14 indicate AT domains present in the corresponding modules of the modular PKSs for erythromycin (6, 7), oleandomycin (36), soraphen A (37), and rapamycin (5, 8) biosynthesis, respectively. Pim00 indicates the AT domain present in PIMS0 (see text). Amino acids identical to the divergent motifs are shown in bold. X is either Arg, Ser, Ala, or Glu. h represents an aliphatic hydrophobic residue. aa, amino acids.

Alignment of other AT domains of the cluster derived from the DNA sequence of subclone ends (when the sequence covered the stretch of 20 amino acids that corresponds to the divergent AT motifs) allowed the identification of another six acetate-incorporating ATs (Pim 00, 05, 06, 08, 09, and 10) (two others remain to be determined to complete the known chain length of pimaricin) and one AT that incorporates propionate extender units (Pim 07, Figs. 2 and 5). Based on the proposed biosynthetic units of pimaricin (11) (Fig. 1), the polyketide synthase should harbor only one such propionate-specific AT, the one comprised in module 7 and responsible for the incorporation of carbons 11, 12, and the exocyclic methyl group that would undergo later oxidation to form the free carboxyl function of the aglycone, as occurs in lucensomycin biosynthesis (28).

The rare Leu codon TTA has been proposed to serve as a device for global regulation in Streptomyces coelicolor (29). There is one such codon in the pimS1 gene, which may allow this regulatory mechanism to control expression of pimS1.

pimS0 Encodes a Separate Module Also Required for Pimaricin Biosynthesis-- Lying downstream of pimS1 and convergently transcribed, there is another open reading frame (pimS0) encoding a protein of 1847 amino acids. The molecular mass of the protein encoded by pimS0 (hereafter named PIMS0) was calculated to be 193,407 Da as a monomer. PIMS0 contains in its C-terminal end a whole PKS module with no domains for reduction or dehydration (i.e. only KS, AT, and ACP; Fig. 4C). Its KS domain lacks the active-site cysteine residue (Fig. 6). Besides, the sequence of its first domain in the N-terminal region, containing about 560 amino acid residues, reveals up to 28% amino acid sequence identity to ATP-dependent carboxylic acid:CoA ligases, including acetyl-CoA synthetases from Bacillus subtilis (EMBL L17309), coumarate-CoA ligases from plants (EMBL X13325, L43362, D39405, U50845), 2,3-dihydroxybenzoate-AMP ligases from E. coli (EMBL X15058), and B. subtilis (U26444), firefly luciferases (EMBL A26772, S33788, S29354), and the long chain fatty acid-carboxylic acid:CoA ligase from Mycobacterium tuberculosis (EMBL Q10776), among others. An ACP domain following the carboxylic acid:CoA ligase domain completes the number of domains housed within this protein (Fig. 4C). Remarkably, the C-terminal ACP has the active-site sequence MGINS instead of the signature sequence LGXDS.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 6.   Alignment of the sequences around the active site Cys (in bold letters) found in KS domain of type I polyketide synthases. Pim00 to Pim04 correspond to the KS domains present in modules 0 to 4 of the PKS for pimaricin biosynthesis. Ery 1, Ole 5, and Rap05 and Rap10 correspond to KS domains present in the modules of PKSs for erythromycin, oleandomycin, and rapamycin, respectively, as in Fig. 5. Note that Pim00 lacks the active-site Cys (see text).

To rule out the possibility that pimS0 could be a remnant of a former gene with no real involvement in pimaricin biosynthesis, its disruption was accomplished. A 1.9-kb BamHI-PstI fragment (containing the coding region for most of the carboxylic acid:CoA ligase domain and the N-terminal end of the KS domain of pimS0) was subcloned into KC515. The method to achieve disruption was as described above for pimS1. Selected disruptants showed no production of pimaricin (not shown), indicating that pimS0 is strictly required for pimaricin biosynthesis.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Polyene macrolides contain very large macrolide rings (sometimes up to 38-membered rings). It is unknown if such large macrolides are synthesized by single PKSs as occurs with 14- or 16-membered macrolides. In this paper we describe the first extensive genetic characterization of a polyene macrolide biosynthetic gene cluster. Southern hybridization experiments were used as means to identify and isolate cosmid clones containing the S. natalensis gene cluster for the 26-membered ring of the macrocyclic polyketide pimaricin.

The most striking feature of the DNA region cloned (110 kb) is that the polyketide synthase genes turned out to be split into two subclusters separated by genes involved in the functionalization of the polyketide backbone. This is the first example of two separate PKSs required for the biosynthesis of different fragments of a single polyketide. In the rapamycin biosynthetic gene cluster, the PKS genes are separated by a pipecolate-activating gene that is directly involved in the formation of the aglycone core of rapamycin (5). Assembly of a complex polyketide core by non-PKS enzymes occurs also in Aspergillus nidulans, where a gene for the biosynthesis of a preformed fatty acid precursor of sterigmatocystin is separated from the type II PKS genes (30). However, this organization of a modular PKS gene cluster separated by genes involved in functionalization of the polyketide backbone is unprecedented.

The arrangement in separate subclusters could suggest that this huge macrolide has been assembled by putting together genes encoding two different polyketide synthases. Future analysis of the DNA sequence composition of the pimaricin synthase subclusters and of other polyene macrolides could provide evidence for this hypothesis.

In total, the giant PIMS1 protein contributes 15 catalytic functions, making this an extremely complex multienzyme, only paralleled by the RAPS proteins of the rapamycin synthase (5). The domain organization of each module is as presented in Fig. 4B. The limits of each domain were readily assigned by comparison with modules from 6-deoxyerythronolide B synthase and the rapamycin synthase (8). In modular PKSs, each module includes the activities required for a round of polyketide chain elongation and reduction, if required. The order of the modules along the polypeptide reflects the order in which each module is used for polyketide chain extension (5-8, 31), and the order of the domains within each module is KS, AT, (dehydratase, enoyl reductase where applicable), beta -ketoreductase, ACP, exactly as for fatty acid synthetase (32), 6-deoxyerythronolide B synthase (24, 25), or the RAPS proteins of the rapamycin synthase (5, 8).

The functionality of PIMS1 in pimaricin biosynthesis was established by inactivating the pimS1 gene by phage-mediated gene disruption. The mutant strain obtained showed a complete lack of pimaricin production, indicating that pimS1 directs the synthesis of pimaricin. Similarly, when we achieved the functional inactivation of pimS0, pimaricin production was completely abrogated, indicating that pimS0 was also involved in pimaricin biosynthesis. In both disrupted mutants, formation of the polyene chromophore was prevented because there was no absorption at the typical peaks of the polyene spectrum (not shown).

Sequencing analysis of pimS0 indicated that in its N-terminal region, PIMS0 contains an ATP-dependent carboxylic acid:CoA ligase. The only similarity to such an adenylate-forming domain in PKS clusters is a sequence of unknown function from B. subtilis (33) and the 3,4-dihydroxycyclohexane carboxylic acid-activating domain present in RAPS 1 and responsible for the initiation of rapamycin biosynthesis (5, 8). Besides, the C terminus of carboxylic acid:CoA ligase PIMS0 contains a whole PKS module with no domains for reduction or dehydration. It is noteworthy that the KS lacks the active-site cysteine residue (see Fig. 6), showing a serine instead, making this KS possibly inactive, because it cannot form the thioester bond with its substrate. It could be argued that this KS might retain some activity because of the formation of O-ester bonds between Ser and the substrate; however, site-directed mutagenesis studies in the tetracenomycin-producing strain Streptomyces glaucescens in which the active-site Cys was replaced by Ser (or Ala) completely abolished the KS activity (34), thus supporting the idea that this PIMS0 KS is functionally inactive.

Modules 2, 3, and 4 of PIMS1 contain dehydratase domains that would catalyze a dehydration of the reduced beta -keto group provided by the corresponding beta -ketoreductase activities present in the same modules (6), yielding three consecutive double bonds in the polyketide core of pimaricin corresponding to the polyene chromophore. Module 1, however, lacks this dehydratase domain. Therefore, it can only process the beta -carbon to a hydroxyl group in the growing polyketide chain (Fig. 7). Thus, there is only one portion of the pimaricin polyketide backbone in which PIMS1 could be involved, i.e. the first four chain elongation steps.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Domain organization and biosynthetic intermediates for PIMS0 and PIMS1. The pimS0 gene product could constitute a loading tool for the acetate starter unit (see text). For domain designations see the abbreviations footnote and the following: CoL, carboxylic acid:CoA ligase; KR, beta -ketoreductase; DH, dehydratase. The KS in PIMS0 (shaded) is presumably inactive (see text).

Module 1 would catalyze the condensation of a starter unit (acetate) to the extender unit (malonate). In modular PKSs, the starter unit is normally provided by a loading domain included at the N terminus of the first multienzyme, as occurs with 6-deoxyerythronolide B synthase 1 (10, 35) or the rapamycin synthase RAPS 1 (5). PIMS1, however, lacks any such loading domain, thus making necessary the interaction of module 1 KS either with free acetyl-CoA or, more likely, with a separate loading protein that would present the starter unit to module 1. Fig. 7 shows the latter possibility. The gene product of pimS0 could be such a loading protein. Its first domain (carboxylic acid:CoA ligase) could activate acetate, forming the acyladenylate that would be transferred by the adjacent ACP to the KS of PIMS0. This KS, being inactive, would not catalyze any condensation reaction but would allow the transfer of the growing polyketide chain to the C-terminal ACP, which would feed the acetyl moiety to module 1 KS of PIMS1 for the first elongation step (Fig. 7). The cloning and specific alteration of the biosynthesis genes for this polyene might allow the engineering of novel analogs with improved antifungal properties.

    ACKNOWLEDGEMENTS

We thank M. R. Rodicio for providing KC515 phage and P. F. Leadlay and J. A. Gil for the kind gift of probes from the rapamycin and the candicidin biosynthesis clusters, respectively.

    FOOTNOTES

* This work was supported by grants from the Diputación de León (INBIOTEC) and the CICYT (BIO96-0583).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ 132221 (pimS0) and AJ 132222 (pimS1).

Dagger Supported by a postdoctoral contract of the Ministry of Education and Science, Madrid.

§ Recipient of a fellowship of the Diputación de León.

To whom correspondence should be addressed. Tel.: +34-987-210308; Fax: +34-987-210388; E-mail: degjmm{at}unileon.es.

2 J. F. Aparicio, A. J. Colina, and J. F. Martín, unpublished results.

    ABBREVIATIONS

The abbreviations used are: PKS, polyketide synthase; ACP, acyl carrier protein; AT, acyltransferase; KS, beta -ketoacyl ACP synthase; kb, kilobase(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. O'Hagan, D. (1991) The Polyketide Metabolites, Ellis Horwood Ltd., Chichester, UK
  2. Hopwood, D. A., and Sherman, D. H. (1990) Annu. Rev. Genet. 24, 37-66[CrossRef][Medline] [Order article via Infotrieve]
  3. Staunton, J. (1991) Angew. Chem. Int. Ed. Engl. 30, 1302-1306
  4. Katz, L., and Donadio, S. (1993) Annu. Rev. Microbiol. 47, 875-912[CrossRef][Medline] [Order article via Infotrieve]
  5. Schwecke, T., Aparicio, J. F., Molnár, Y., König, A., Khaw, L. E., Haydock, S. F., Oliynyk, M., Caffrey, P., Cortés, J., Lester, J. B., Böhm, G. A., Staunton, J., and Leadlay, P. F. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7839-7843[Abstract]
  6. Donadio, S., Staver, M. J., McAlpine, J. B., Swanson, S. J., and Katz, L. (1991) Science 252, 675-679[Medline] [Order article via Infotrieve]
  7. Cortés, J., Haydock, S. F., Roberts, G. A., Bevitt, D. J., and Leadlay, P. F. (1990) Nature 348, 176-178[CrossRef][Medline] [Order article via Infotrieve]
  8. Aparicio, J. F., Molnár, I., Schwecke, T., König, A., Haydock, S. F., Khaw, L. E., Staunton, J., and Leadlay, P. F. (1996) Gene 169, 9-16[CrossRef][Medline] [Order article via Infotrieve]
  9. Marsden, A. F. A., Caffrey, P., Aparicio, J. F., Loughran, M. S., Staunton, J., and Leadlay, P. F. (1994) Science 263, 378-380[Medline] [Order article via Infotrieve]
  10. Aparicio, J. F., Caffrey, P., Marsden, A. F. A., Staunton, J., and Leadlay, P. F. (1994) J. Biol. Chem. 269, 8524-8528[Abstract/Free Full Text]
  11. Martín, J. F. (1977) Annu. Rev. Microbiol. 31, 12-38
  12. Gil, J. A., and Martín, J. F. (1997) in Biotechnology of Antibiotics (Strohl, W. R., ed), 2nd Ed., pp. 551-576, Marcel Dekker, Inc., New York
  13. Omura, S., and Tanaka, H. (1984) in Macrolide Antibiotics, Chemistry, Biology, and Practice (Omura, S., ed), pp. 351-404, Academic Press, Inc., NY
  14. Bolard, J. (1986) Biochim. Biophys. Acta 719, 11-17
  15. Rodicio, M. R., Bruton, C. J., and Chater, K. F. (1985) Gene 34, 283-292[CrossRef][Medline] [Order article via Infotrieve]
  16. Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Bruton, C. J., Kieser, H. M., Lydiate, D. J., Smith, C. P., Ward, J. M., and Schrempf, H. (1985) Genetic Manipulation of Streptomyces: A Laboratory Manual, John Innes Foundation, Norwich, UK
  17. Chater, K. F., Bruton, C. J., and Suárez, J. E. (1981) Gene 14, 183-194[CrossRef][Medline] [Order article via Infotrieve]
  18. Martín, J. F., and Demain, A. L. (1975) Biochem. Biophys. Res. Commun. 71, 1103-1109
  19. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  20. Hanahan, D. (1985) in DNA Cloning: A Practical Approach (Glover, D. M., ed), pp. 109-132, IRL Press at Oxford University Press, Oxford
  21. Criado, L. M., Martín, J. F., and Gil, J. A. (1993) Gene 126, 135-139[CrossRef][Medline] [Order article via Infotrieve]
  22. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract]
  23. Devereux, J., Haeberli, P., and Smithies, O. (1984) Nucleic Acids Res. 12, 387-395[Abstract]
  24. Bevitt, D. J., Cortés, J., Haydock, S. F., and Leadlay, P. F. (1992) Eur. J. Biochem. 204, 39-49[Abstract]
  25. Donadio, S., and Katz, L. (1992) Gene 11, 51-60
  26. Scrutton, N. S., Berry, A., and Perham, R. N. (1990) Nature 343, 38-43[CrossRef][Medline] [Order article via Infotrieve]
  27. Haydock, S., Aparicio, J. F., Molnár, I., Schwecke, T., König, A., Marsden, A. F. A., Galloway, I. S., Staunton, J., and Leadlay, P. F. (1995) FEBS Lett. 374, 246-248[CrossRef][Medline] [Order article via Infotrieve]
  28. Manwaring, D. G., Rickards, R. W., Gaudiano, G., and Nicolella, V. (1969) J. Antibiot. (Tokyo) 22, 545-550[Medline] [Order article via Infotrieve]
  29. Leskiw, B. K., Lawlor, E. J., Fernández-Abalos, J. M., and Chater, K. F. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2461-2465[Abstract]
  30. Brown, D. W., Adams, T. H., and Keller, N. P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14873-14877[Abstract/Free Full Text]
  31. MacNeil, D. J., Occi, J. L., Gewain, K. M., MacNeil, T., Gibbons, P. H., Ruby, C. L., and Danis, S. J. (1992) Gene 115, 119-125[CrossRef][Medline] [Order article via Infotrieve]
  32. Wakil, S. J. (1989) Biochemistry 28, 4523-4530[Medline] [Order article via Infotrieve]
  33. Albertini, A. M., Caramori, T., Scoffone, F., Scotti, C., and Galizzi, A. (1995) Microbiology 141, 299-309[Abstract]
  34. Meurer, G., and Hutchinson, C. R. (1995) J. Bacteriol. 177, 477-481[Abstract]
  35. Staunton, J., Caffrey, P., Aparicio, J. F., Robets, G. A., Bethell, S. S., and Leadlay, P. F. (1996) Nat. Struct. Biol. 3, 188-192[Medline] [Order article via Infotrieve]
  36. Swan, D. G., Rodríguez, A. M., Vilches, C., Méndez, C., and Salas, J. A. (1994) Mol. Gen. Genet. 242, 358-362[Medline] [Order article via Infotrieve]
  37. Schupp, T., Toupet, C., Cluzel, B., Neff, S., Hill, S., Beck, J. J., and Ligon, J. M. (1995) J. Bacteriol. 177, 3673-3679[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.